Continued HER2 Suppression With Lapatinib Plus Trastuzumab Versus Trastuzumab Alone
Clinical trial NCT00968968 · TERMINATED
Trial details
- NCT number
- NCT00968968
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-01-20
- Primary completion
- 2014-02-21
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.